Cartesian Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $137.4M | $159.9M | $114.1M |
| FY2022 | $72.1M | $165.9M | $106.4M |
| FY2023 | $444.7M | $305.1M | $76.9M |
| FY2024 | $441.8M | $435.0M | $212.6M |
| FY2025 | $422.7M | $296.4M | $125.1M |